MSTN and cancer: Hepatic alterations have been associated with cancer-induced muscle wasting [41,42] and furthermore liver fibrosis-induced muscle atrophy was promoted by elevated levels of circulating IL-6, TNF-α and myostatin during progression of liver disease [43,44].